Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Blood
|
March 6, 2023
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma
Yao Yao, Jessica Fong Ng, Woojun Daniel Park, et al.
Journal of Medicinal Chemistry
|
March 22, 2023
Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors
Wenchao Lu, Mengyang Fan, Wenzhi Ji, et al.
Nature Genetics
|
January 31, 2018
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
Rhamy Zeid, Matthew A Lawlor, Evon Poon, et al.
Cancer Discovery
|
April 11, 2022
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts
Jana M Ellegast, Gabriela Alexe, Amanda Hamze, et al.
Cancer Cell
|
July 30, 2021
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Bo Kyung A Seong, Neekesh V Dharia, Shan Lin, et al.
Nature
|
February 28, 2017
Transcription control by the ENL YEATS domain in acute leukaemia
Michael A Erb, Thomas G Scott, Bin E Li, et al.
Elife
|
November 14, 2018
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
Mei Zeng, Nicholas P Kwiatkowski, Tinghu Zhang, et al.
Science Advances
|
January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis
Dana K Mitchell, Kylee Brewster, Li Jiang, et al.
Blood Cancer Journal
|
May 21, 2021
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
Warren Fiskus, Christopher P Mill, Behnam Nabet, et al.
Nature Communications
|
January 2, 2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment
Bassel Alsaed, Linh Lin, Jieun Son, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Blood
|
March 6, 2023
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma
Yao Yao, Jessica Fong Ng, Woojun Daniel Park, et al.
Journal of Medicinal Chemistry
|
March 22, 2023
Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors
Wenchao Lu, Mengyang Fan, Wenzhi Ji, et al.
Nature Genetics
|
January 31, 2018
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
Rhamy Zeid, Matthew A Lawlor, Evon Poon, et al.
Cancer Discovery
|
April 11, 2022
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts
Jana M Ellegast, Gabriela Alexe, Amanda Hamze, et al.
Cancer Cell
|
July 30, 2021
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Bo Kyung A Seong, Neekesh V Dharia, Shan Lin, et al.
Nature
|
February 28, 2017
Transcription control by the ENL YEATS domain in acute leukaemia
Michael A Erb, Thomas G Scott, Bin E Li, et al.
Elife
|
November 14, 2018
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
Mei Zeng, Nicholas P Kwiatkowski, Tinghu Zhang, et al.
Science Advances
|
January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis
Dana K Mitchell, Kylee Brewster, Li Jiang, et al.
Blood Cancer Journal
|
May 21, 2021
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
Warren Fiskus, Christopher P Mill, Behnam Nabet, et al.
Nature Communications
|
January 2, 2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment
Bassel Alsaed, Linh Lin, Jieun Son, et al.
Page
of 6